Cargando…

Promising Therapeutic Impact of a Selective Estrogen Receptor Downregulator, Fulvestrant, as Demonstrated In Vitro upon Low-Grade Serous Ovarian Carcinoma Cell Lines

Few studies have reported hormonal agent use in the treatment of low-grade serous ovarian carcinomas (LGSOCs), which are chemoresistant. Considering the need for novel effective therapies, we investigated the hormone receptor expression and hormonal inhibition efficacy in LGSOCs. Using immunohistoch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shanta, Kamrunnahar, Nakayama, Kentaro, Hossain, Mohammad Mahmud, Razia, Sultana, Ishibashi, Tomoka, Ishikawa, Masako, Yamashita, Hitomi, Kanno, Kosuke, Sato, Seiya, Nakayama, Satoru, Otsuki, Yoshiro, Kyo, Satoru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221871/ https://www.ncbi.nlm.nih.gov/pubmed/35735430 http://dx.doi.org/10.3390/curroncol29060321

Ejemplares similares

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

Promising Therapeutic Impact of Immune Checkpoint Inhibitors in Type II Endometrial Cancer Patients with Deficient Mismatch Repair Status
por: Sawada, Kiyoka, et al.
Publicado: (2023)

Establishment of a Novel In Vitro Model of Endometriosis with Oncogenic KRAS and PIK3CA Mutations for Understanding the Underlying Biology and Molecular Pathogenesis
por: Hossain, Mohammad Mahmud, et al.
Publicado: (2021)

Histological and Genetic Diversity in Ovarian Mucinous Carcinomas: A Pilot Study
por: Razia, Sultana, et al.
Publicado: (2023)

Frequent PIK3CA mutation in normal endometrial gland drives spheroid formation and may be involved in stem cell propagation
por: Sato, Seiya, et al.
Publicado: (2023)

High Frequency of PIK3CA Mutations in Low-Grade Serous Ovarian Carcinomas of Japanese Patients
por: Ishibashi, Tomoka, et al.
Publicado: (2019)

Ovarian Endometrioid and Clear Cell Carcinomas with Low Prevalence of Microsatellite Instability: A Unique Subset of Ovarian Carcinomas Could Benefit from Combination Therapy with Immune Checkpoint Inhibitors and Other Anticancer Agents
por: Nonomura, Yuki, et al.
Publicado: (2022)

Prognostic Value of Peripheral Blood Lymphocyte Telomere Length in Gynecologic Malignant Tumors
por: Shanta, Kamrunnahar, et al.
Publicado: (2020)

Identifying the Carcinogenic Mechanism of Malignant Struma Ovarii Using Whole-Exome Sequencing and DNA Methylation Analysis
por: Yamashita, Hitomi, et al.
Publicado: (2023)

Mutation Profiles of Ovarian Seromucinous Borderline Tumors in Japanese Patients
por: Sasamori, Hiroki, et al.
Publicado: (2022)

Preoperative tumor size is associated with deep myometrial invasion and lymph node metastases and is a negative prognostic indicator for patients with endometrial carcinoma
por: Nakamura, Kohei, et al.
Publicado: (2018)

Lynch Syndrome-Related Clear Cell Carcinoma of the Cervix: A Case Report
por: Nakamura, Kohei, et al.
Publicado: (2018)

Pregnancy by Assisted Reproductive Technology Is Associated with Shorter Telomere Length in Neonates
por: Minamoto, Toshiko, et al.
Publicado: (2020)

Ultrasound-guided intranodal lymphangiography with lipiodol for treatment of chylous ascites following surgery for ovarian cancer: A case report
por: Nakamura, Kohei, et al.
Publicado: (2018)

High PD-1 expression level is associated with an unfavorable prognosis in patients with cervical adenocarcinoma
por: Ishikawa, Masako, et al.
Publicado: (2020)

The Case of an Endometrial Cancer Patient with Breast Cancer Who Has Achieved Long-Term Survival via Letrozole Monotherapy
por: Ishikawa, Masako, et al.
Publicado: (2023)

Prognostic significance of pre-treatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in non-surgically treated uterine cervical carcinoma
por: Nakamura, Kohei, et al.
Publicado: (2018)

Clinical Landscape of PARP Inhibitors in Ovarian Cancer: Molecular Mechanisms and Clues to Overcome Resistance
por: Kyo, Satoru, et al.
Publicado: (2022)

Loss of autophagy-related protein Beclin 1 may define poor prognosis in ovarian clear cell carcinomas
por: KATAGIRI, HIROSHI, et al.
Publicado: (2015)

Dedifferentiated Endometrial Carcinoma Could be A Target for Immune Checkpoint Inhibitors (Anti PD-1/PD-L1 Antibodies)
por: Ono, Ruriko, et al.
Publicado: (2019)

P16(INK4A) expression might be associated with a favorable prognosis for cervical adenocarcinoma via dysregulation of the RB pathway
por: Ishikawa, Masako, et al.
Publicado: (2021)

Whole-Exome Sequencing of Rare Site Endometriosis-Associated Cancer
por: Kurose, Sonomi, et al.
Publicado: (2021)

Comparison between bidirectional Stratafix(®) barbed suture and conventional suture in laparoscopic myomectomy: a retrospective study
por: Nakayama, Kentaro, et al.
Publicado: (2020)

Clinical Outcomes of Genotype-Matched Therapy for Recurrent Gynecological Cancers: A Single Institutional Experience
por: Sawada, Kiyoka, et al.
Publicado: (2021)

KRAS/BRAF Analysis in Ovarian Low-Grade Serous Carcinoma Having Synchronous All Pathological Precursor Regions
por: Nakamura, Kohei, et al.
Publicado: (2016)

Underdiagnosis of early cervical cancer with an invisible cervical transformation zone in an elderly patient: A case report
por: Ishikawa, Masako, et al.
Publicado: (2021)

Single-port laparoscopic surgery for ovarian cystectomy: A single-center analysis of 25 cases
por: Nakayama, Kentaro, et al.
Publicado: (2021)

Neutropenic enterocolitis-induced sepsis and disseminated intravascular coagulation after chemotherapy: a case report
por: Ishikawa, Masako, et al.
Publicado: (2021)

Metastasis of breast cancer to an endometrial polyp, the cervix and a leiomyoma: A case report and review of the literature
por: Razia, Sultana, et al.
Publicado: (2017)

ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma
por: Sato, Emi, et al.
Publicado: (2018)

Reconstitution of high-grade serous ovarian carcinoma from primary fallopian tube secretory epithelial cells
por: Nakamura, Kohei, et al.
Publicado: (2017)

Genetic analysis and phosphoinositide 3-kinase/protein kinase B signaling pathway status in ovarian endometrioid borderline tumor samples
por: Nakamura, Kohei, et al.
Publicado: (2018)

Mucinous borderline ovarian tumors with BRAF(V600E) mutation may have low risk for progression to invasive carcinomas
por: Ohnishi, Kaori, et al.
Publicado: (2020)

Affinity-purified DNA-based mutation profiles of endometriosis-related ovarian neoplasms in Japanese patients
por: Ishikawa, Masako, et al.
Publicado: (2018)

Effect of Muscle Loss but Not Fat Loss during Primary Debulking Surgery and Chemotherapy on Prognosis of Patients with Ovarian Cancer
por: Nakayama, Naomi, et al.
Publicado: (2022)

Microsatellite instability is a biomarker for immune checkpoint inhibitors in endometrial cancer
por: Yamashita, Hitomi, et al.
Publicado: (2017)

Letrozole as second-line hormonal treatment for recurrent low-grade endometrial stromal sarcoma: A case report and review of the literature
por: Nakamura, Kohei, et al.
Publicado: (2016)

The diagnostic utility of PAX8 immunostaining of malignant peritoneal mesothelioma presenting as serous ovarian carcinoma: A single-center report of two cases
por: Nakamura, Kohei, et al.
Publicado: (2017)

Pathological findings in the endometrium after microwave endometrial ablation
por: Nakayama, Kentaro, et al.
Publicado: (2020)

Relationship between Microsatellite Instability, Immune Cells Infiltration, and Expression of Immune Checkpoint Molecules in Ovarian Carcinoma: Immunotherapeutic Strategies for the Future
por: Yamashita, Hitomi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cdutqegutkop08a0h4bqfaa7lu